enVVeno Medical (STU:5HJ0) FCF Margin %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:5HJ0 enVVeno Medical Corp STU:5HJ0
26 GF Score
Price €10.15
! 3 Warning Signs
View Full Analysis

What is enVVeno Medical FCF Margin %?

enVVeno Medical STU:5HJ0 26 FCF Margin % is 0.00% as of Jun. 2026. GuruFocus rates STU:5HJ0 with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, enVVeno Medical ranks worse than 122699.26% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. enVVeno Medical's Free Cash Flow for the three months ended in Jun. 2026 was €-3.08 Mil. enVVeno Medical's Revenue for the three months ended in Jun. 2026 was €0.00 Mil. Therefore, enVVeno Medical's FCF Margin % for the quarter that ended in Jun. 2026 was 0.00%.

As of today, enVVeno Medical's current FCF Yield % is -190.41%.

The historical rank and industry rank for enVVeno Medical's FCF Margin % or its related term are showing as below:


During the past 11 years, the highest FCF Margin % of enVVeno Medical was -482.32%. The lowest was -20193.55%. And the median was -2201.85%.

STU:5HJ0's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.64
* Ranked among companies with meaningful FCF Margin % only.


enVVeno Medical FCF Margin % Related Terms


enVVeno Medical FCF Margin % Historical Data

* Premium members only.

The historical data trend for enVVeno Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

enVVeno Medical FCF Margin % Chart

enVVeno Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

enVVeno Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:5HJ0 vs CODX, HSCS, AIDX: FCF Margin % Comparison

For the Medical Devices subindustry, enVVeno Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


enVVeno Medical FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, enVVeno Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where enVVeno Medical's FCF Margin % falls into.


STU:5HJ0
26GF Score
enVVeno Medical Corp STU:5HJ0
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

enVVeno Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

enVVeno Medical's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.299/0
= %

enVVeno Medical's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-3.081/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
enVVeno Medical (STU:5HJ0) has a FCF Margin % of 0.00% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on enVVeno Medical and its competitors. According to the industry distribution chart, enVVeno Medical ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is enVVeno Medical's FCF Margin % too high?
enVVeno Medical's current FCF Margin % is 0.00%. Based on the distribution chart, enVVeno Medical ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, enVVeno Medical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does enVVeno Medical's FCF Margin % compare to CODX and HSCS?
According to the Medical Devices & Instruments industry distribution chart, enVVeno Medical ranks #999999 out of 815 companies for FCF Margin %. This places enVVeno Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on enVVeno Medical and its competitors. enVVeno Medical's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is enVVeno Medical stock overvalued right now?
enVVeno Medical (STU:5HJ0) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. enVVeno Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For enVVeno Medical (STU:5HJ0), the current FCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

enVVeno Medical Business Description

Other Exchanges NVNO:USA
Address 70 Doppler, Irvine, CA, USA, 92618
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
26GF Score

Get the complete analysis for STU:5HJ0

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.15
Price